galenIQ™ cannot be used as substrate by most of the bacteria occuring in the oral cavity. Therefore, it helps to reduce the formation of dental plaque . Numerous human in vivo trials demonstrate that the pH value in the plaque remains above the critical level of 5.7 when galenIQ™ containing products are consumed instead of products made of sugar or glucose.

Combined with the good organoleptical properties, the non-cariogenicity makes galenIQ™ an attractive choice for many buccal applications , such as sucking tablets, chewables or lozenges.